Richard Malley

11.1k total citations · 2 hit papers
134 papers, 7.6k citations indexed

About

Richard Malley is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Richard Malley has authored 134 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Epidemiology, 45 papers in Microbiology and 30 papers in Immunology. Recurrent topics in Richard Malley's work include Pneumonia and Respiratory Infections (93 papers), Respiratory viral infections research (65 papers) and Bacterial Infections and Vaccines (44 papers). Richard Malley is often cited by papers focused on Pneumonia and Respiratory Infections (93 papers), Respiratory viral infections research (65 papers) and Bacterial Infections and Vaccines (44 papers). Richard Malley collaborates with scholars based in United States, United Kingdom and Brazil. Richard Malley's co-authors include Marc Lipsitch, Claudette M. Thompson, Daniel M. Weinberger, Porter Anderson, Nathan Kuppermann, Ying‐Jie Lu, Krzysztof Trzciński, Kristin Moffitt, Amit Srivastava and Lise E. Nigrovic and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard Malley

132 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serotype replacement in disease after pneumococcal vaccination

2011 713 citations Richard Malley, Marc Lipsitch et al. profile →
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection

2003 536 citations Richard Malley, Philipp Henneke et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Richard Malley

Since Specialization

Citations

This map shows the geographic impact of Richard Malley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Malley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Malley more than expected).

Fields of papers citing papers by Richard Malley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Malley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Malley. The network helps show where Richard Malley may publish in the future.

Co-authorship network of co-authors of Richard Malley

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Malley. A scholar is included among the top collaborators of Richard Malley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Malley. Richard Malley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CC180 clade dynamics do not universally explain Streptococcus pneumoniae serotype 3 persistence post-vaccine: a global comparative population genomics study 2025 ·EBioMedicine ·Sydney Stanley, Catarina Silva‐Costa, (unknown), José Melo‐Cristino, Richard Malley, Mário Ramirez	2
2	Evaluation of a Quadrivalent Shigella flexneri Serotype 2a, 3a, 6, and Shigella sonnei O-Specific Polysaccharide and IpaB MAPS Vaccine 2024 ·Vaccines ·(unknown), Joyce Gong, (unknown), (unknown), (unknown), (unknown), (unknown), Calman A. MacLennan, (unknown), Richard Malley, Ying‐Jie Lu	1
3	Surface protein distribution in Group B Streptococcus isolates from South Africa and identifying vaccine targets through in silico analysis 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Ziyaad Dangor, Nancy Hosken, Richard Malley, Shabir A. Madhi, Gaurav Kwatra	2
4	Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial 2024 ·Vaccine ·Dorota Borys, Ronald Smulders, Miwa Haranaka, Takashi Nakano, Gurunadh R. Chichili, Masaki Ebara, (unknown), (unknown), (unknown), Jasdeep S. Nanra, Richard Malley, Shite Sebastian	0
5	Vaccination for healthy aging 2024 ·Science Translational Medicine ·David E. Bloom, Simone Pecetta, Francesco Berlanda Scorza, Andrea Carfı́, Bruce Carleton, Mariateresa Cipriano, Kathryn M. Edwards, Gianmarco Gasperini, Richard Malley, Arindam Nandi, (unknown), Lynda M. Stuart, Steve Black, Rino Rappuoli	7
6	Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice 2024 ·Vaccine ·(unknown), Sam Manna, Eileen M. Dunne, (unknown), Casey L. Pell, Natalie L. Patterson, (unknown), Poshmaal Dhar, David Goldblatt, Kim Mulholland, Paul V. Licciardi, Roy M. Robins‐Browne, Richard Malley, Odilia Wijburg, Catherine Satzke	1
7	A MAPS Vaccine Induces Multipronged Systemic and Tissue-Resident Cellular Responses and Protects Mice against Mycobacterium tuberculosis 2023 ·mBio ·Joanne M. O’Hara, Shoko Wakabayashi, Noman Siddiqi, Elaine Cheung, Gregory H. Babunovic, Claudette M. Thompson, Ying‐Jie Lu, Eric J. Rubin, Richard Malley, Fan Zhang	4
8	Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A 2023 ·Vaccines ·(unknown), Joyce Gong, (unknown), Claudette M. Thompson, (unknown), (unknown), (unknown), Calman A. MacLennan, Fan Zhang, Richard Malley, Ying‐Jie Lu	12
9	Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPSTM) SARS-CoV-2 Vaccine 2022 ·Vaccines ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yannic C. Bartsch, Galit Alter, Richard Malley, Gilles Besin	2
10	A Bivalent MAPS Vaccine Induces Protective Antibody Responses against Salmonella Typhi and Paratyphi A 2022 ·Vaccines ·Fan Zhang, (unknown), Joyce Gong, (unknown), (unknown), (unknown), Richard Malley, Ying‐Jie Lu	12
11	Prospective cohort study of children with suspected SARS-CoV-2 infection presenting to paediatric emergency departments: a Paediatric Emergency Research Networks (PERN) Study Protocol 2021 ·BMJ Open ·Anna Funk, Todd A. Florin, Stuart R. Dalziel, Santiago Mintegi, Marina I. Salvadori, Daniel J. Tancredi, Mark I. Neuman, Daniel C. Payne, Amy C. Plint, Terry P. Klassen, Richard Malley, Lilliam Ambroggio, (unknown), Nathan Kuppermann, Stephen B. Freedman	10
12	A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults 2020 ·The Pediatric Infectious Disease Journal ·Cheryl Keech, (unknown), Porter Anderson, (unknown), Jorge Flores, David Goldblatt, David E. Briles, John Hural, Richard Malley, Mark R. Alderson	19
13	Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity 2013 ·Proceedings of the National Academy of Sciences ·Fan Zhang, Ying‐Jie Lu, Richard Malley	87
14	A Novel Role for IκB Kinase (IKK) α and IKKβ in ERK-Dependent Up-Regulation of MUC5AC Mucin Transcription by Streptococcus pneumoniae 2007 ·The Journal of Immunology ·Un‐Hwan Ha, Jae Hyang Lim, Hirofumi Jono, Tomoaki Koga, Amit Srivastava, Richard Malley, Gilles Pagès, Jacques Pouysségur, Jiandong Li	61
15	Serum Antipneumococcal Antibodies and Pneumococcal Colonization in Adults with Chronic Obstructive Pulmonary Disease 2007 ·The Journal of Infectious Diseases ·Richard Malley, Marc Lipsitch, Debby Bogaert, Claudette M. Thompson, Peter W. M. Hermans, A. Claire Watkins, Sanjay Sethi, Timothy F. Murphy	22
16	c-Jun Kinase Is a Critical Signaling Molecule in a Neonatal Model of Group B Streptococcal Sepsis 2006 ·The Journal of Immunology ·Sybille Landwehr-Kenzel, Giuseppe Mancuso, Richard Malley, Giuseppe Teti, Douglas T. Golenbock, Philipp Henneke	46
17	CD4 ⁺ T cells mediate antibody-independent acquired immunity to pneumococcal colonization 2005 ·Proceedings of the National Academy of Sciences ·Richard Malley, Krzysztof Trzciński, Amit Srivastava, Claudette M. Thompson, Porter Anderson, Marc Lipsitch	270
18	Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways 2002 ·The Journal of Immunology ·Philipp Henneke, Osamu Takeuchi, Richard Malley, Egil Lien, Robin R. Ingalls, Mason W. Freeman, Tanya N. Mayadas, Victor Nizet, Shizuo Akira, Dennis L. Kasper, Douglas T. Golenbock	120
19	FATAL DISSEMINATED CANDIDA LUSITANIAE INFECTION IN AN INFANT WITH CHRONIC GRANULOMATOUS DISEASE 2002 ·The Pediatric Infectious Disease Journal ·Ofer Levy, Jean‐Pierre Bourquin, Alisa McQueen, Alan Cantor, Catherine S. Lachenauer, Richard Malley	13
20	Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions 2000 ·The Pediatric Infectious Disease Journal ·Richard Malley, Louis Vernacchio, John P. DeVincenzo, Octavio Ramilo, Penelope H. Dennehy, H. Cody Meissner, William C. Gruber, Hasan S. Jafri, Pablo J. Sánchez, Kristin MacDonald, (unknown), Claudette M. Thompson, Donna M. Ambrosino	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact